I'm interested in discussing some ambiguities in the CAP checklist for flow
cytometry. If anyone is amenable to this, I'd appreciate hearing from you. If
this is something that strikes a chord in a significant number of people,
perhaps we can discuss it "on the air", but for the sake of bandwidth, and the
forebearance of "research types", it might be appropriate to have inital
correspondence "off-line."
Thanks for your indulgence.
Marc Langweiler voice (603) 650-4924
DMS Pathology fax (603) 650-6120
marcl@dartmouth.edu
http://mmm.dartmouth.edu/Pages/marcl/flowcyt.html